Filtered By:
Therapy: Hormonal Therapy

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 218 results found since Jan 2013.

Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases.
CONCLUSION: Our study shows a very low report of cardiovascular effects under testosterone, all doubtful. Pending further studies, it seems reasonable to consider the cardiovascular risk of patients who are candidates for hormone therapy for age-related androgen deficiency. LEVEL OF EVIDENCE: 3. PMID: 29650456 [PubMed - as supplied by publisher]
Source: Progres en Urologie - April 15, 2018 Category: Urology & Nephrology Tags: Prog Urol Source Type: research

Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy
Conclusions: Discontinuation of postmenopausal HT may be associated with increased risk of cardiac and stroke death in the first posttreatment year. Further investigation is required to evaluate causality of the observed associations.
Source: Menopause - March 23, 2018 Category: OBGYN Tags: Original Articles Source Type: research

Concurrent use of Chinese herbal medicine among hormone users and its association with ischemic stroke risk: A population-based study
Conclusion We found that combined use of HT and CHM was associated with a lower risk of IS. Further study is needed to examine possible mechanism underlying this association. Graphical abstract
Source: Journal of Ethnopharmacology - February 15, 2018 Category: Drugs & Pharmacology Source Type: research

In the Clinic-Stroke: Early Hormone Therapy Not Associated with Greater Stroke Risk in Postmenopausal Women
No abstract available
Source: Neurology Today - January 25, 2018 Category: Neurology Tags: Features Source Type: research

Impact of microbiota on the use and effects of isoflavones in the relief of climacteric symptoms in menopausal women – A review
Publication date: February 2018 Source:Journal of Functional Foods, Volume 41 Author(s): Naice E.S. Monteiro, Lívia D. Queirós, Danielle B. Lopes, Adriana O. Pedro, Gabriela A. Macedo Menopause is a natural event that occurs in women around the age of 50 years, causing irregularities in the menstrual cycle until its complete end, due to the hormonal deficit, especially estrogen, that causes several unpleasant urogenital and vasomotor symptoms. Hormone replacement therapy has many benefits, but should be prescribed with caution in women with a history of stroke, thromboembolic events, certain types of cancer, or increa...
Source: Journal of Functional Foods - December 22, 2017 Category: Nutrition Source Type: research

Hormone therapy after menopause not linked to stroke risk
Women who undergo hormone therapy after menopause are not at higher risk of stroke, research published in the journalPLOS Medicine suggests.Psych Central
Source: Society for Endocrinology - November 27, 2017 Category: Endocrinology Source Type: news

Stopping HRT after menopause may increase cardiovascular disease risk
Research published inMenopause reports that women who stop hormone therapy after menopause are at higher risk of cardiac and stroke death.Healio
Source: Society for Endocrinology - November 17, 2017 Category: Endocrinology Source Type: news

Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
by Germ án D. Carrasquilla, Paolo Frumento, Anita Berglund, Christer Borgfeldt, Matteo Bottai, Chiara Chiavenna, Mats Eliasson, Gunnar Engström, Göran Hallmans, Jan-Håkan Jansson, Patrik K. Magnusson, Peter M. Nilsson, Nancy L. Pedersen, Alicja Wolk, Karin Leander BackgroundRecent research indicates a favourable influence of postmenopausal hormone therapy (HT) if initiated early, but not late, on subclinical atherosclerosis. However, the clinical relevance of timing of HT initiation for hard end points such as stroke remains to be determined. Further, no previous research has considered the timing of initiation of HT i...
Source: PLoS Medicine - November 17, 2017 Category: Internal Medicine Authors: Germ án D. Carrasquilla Source Type: research

CV Deaths in Younger Women Rise During Year After Stopping HT CV Deaths in Younger Women Rise During Year After Stopping HT
Women younger than 60 years had a higher risk for cardiac and stroke death during the first year after stopping hormone therapy compared with those not taking HT and those continuing HT, a study found.Medscape Medical News
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Stopping hormone therapy increases risk of cardiac complications
According to a study, published inMenopause, discontinuing hormone therapy increases the risk of heart–related complications and stroke.News Medical
Source: Society for Endocrinology - November 9, 2017 Category: Endocrinology Source Type: news

Risk of cardiac and stroke death increases after discontinuing hormone therapy
(The North American Menopause Society (NAMS)) Hormone therapy (HT) continues to be a hotly debated topic. The benefits of estrogen to the heart, however, appear to be universally accepted. A new study demonstrates that the risk of cardiac and stroke death actually increases in the first year after discontinuation of HT. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

In Defense of Progesterone: A Review of the Literature.
Conclusions • Physicians should have no hesitation prescribing natural progesterone. The evidence is clear that progesterone does not cause breast cancer. Indeed, progesterone is protective and preventative of breast cancer. PMID: 29055286 [PubMed - as supplied by publisher]
Source: Alternative Therapies in Health and Medicine - October 21, 2017 Category: Complementary Medicine Authors: Lieberman A, Curtis L Tags: Altern Ther Health Med Source Type: research

Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review
ConclusionsEvidence supporting bone and cardiovascular benefits of HT in women with POI is limited by high risk of bias, reliance on surrogate outcomes, and heterogeneity of trials regarding the formulation, dose, route of administration, and regimen of HT. Further research addressing patient important outcomes such as fractures, stroke, and cardiovascular mortality are crucial to optimize benefits of this therapy.
Source: Endocrine - October 16, 2017 Category: Endocrinology Source Type: research

Hormone Therapy May Be OK for Women With Migraines
Heightened risk of stroke not borne out in preliminary study
Source: WebMD Health - October 11, 2017 Category: Consumer Health News Source Type: news